Describe prior authorization and step therapy within Part D formularies.

Study for America's Health Insurance Plans (AHIP) 4 Test. Engage with comprehensive multiple choice questions, hints, and detailed explanations. Prepare thoroughly for your insurance planning exam!

Multiple Choice

Describe prior authorization and step therapy within Part D formularies.

Explanation:
Step therapy in Part D formularies is a utilization-management approach where a patient must try a lower-cost, evidence-based option before a more expensive drug will be approved for coverage. The idea is to start with the most cost-effective therapy and only move to the pricier option if the cheaper choice proves ineffective or unsuitable. For example, a plan might require trying a generic antidepressant before approving a more expensive brand-name option. Prior authorization is a separate process in which the insurer must give approval before a specific drug is covered, often used for high-cost or high-risk medications or when clinical documentation is needed. The statement that best describes the mechanism you’d encounter in the formulary is the one that emphasizes trying cheaper options first before approving higher-cost drugs.

Step therapy in Part D formularies is a utilization-management approach where a patient must try a lower-cost, evidence-based option before a more expensive drug will be approved for coverage. The idea is to start with the most cost-effective therapy and only move to the pricier option if the cheaper choice proves ineffective or unsuitable. For example, a plan might require trying a generic antidepressant before approving a more expensive brand-name option.

Prior authorization is a separate process in which the insurer must give approval before a specific drug is covered, often used for high-cost or high-risk medications or when clinical documentation is needed. The statement that best describes the mechanism you’d encounter in the formulary is the one that emphasizes trying cheaper options first before approving higher-cost drugs.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy